Preventing pulmonary embolism: What you can do

Journal of Respiratory Diseases

Volumn 17, Issue 10, 1996, Pages

  Barnhart, Scott ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; DEXTRAN; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG EFFICACY; HEPARINIZATION; HUMAN; LUNG EMBOLISM; META ANALYSIS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PARTIAL THROMBOPLASTIN TIME; PROPHYLAXIS; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOEMBOLISM; VENA CAVA FILTER;

EID: 0029970891     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (1)

1. Andersen FA, Wheeler B, Goldberg RJ, et al: A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1991;151:933-938.